Development of a Suitable Physical Form for a Sphingosine-1-phosphate Receptor Agonist
Authors:
- 20 August 2011
- journal article
- review article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 15 (6) , 1336-1343
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5ACS Medicinal Chemistry Letters, 2010
- Development of a Suitable Salt Form for a GPR40 Receptor AgonistOrganic Process Research & Development, 2010
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple SclerosisNew England Journal of Medicine, 2010
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple SclerosisNew England Journal of Medicine, 2010
- Sphingosine 1-Phosphate Receptor SignalingAnnual Review of Biochemistry, 2009
- “Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic TargetsPharmacological Reviews, 2008
- An Approach to Early-Phase Salt Selection: Application to NBI-75043Organic Process Research & Development, 2007
- Salt Selection and Optimisation Procedures for Pharmaceutical New Chemical EntitiesOrganic Process Research & Development, 2000
- Solubilization of Nicardipine Hydrochloride via Complexation and Salt FormationJournal of Pharmaceutical Sciences, 1994
- Salt selection for basic drugsInternational Journal of Pharmaceutics, 1986